Association of Fasciola hepatica Infection with Liver Fibrosis, Cirrhosis, and Cancer: A Systematic Review

PLoS Neglected Tropical Diseases

Volumn 10, Issue 9, 2016, Pages

  Machicado, Claudia ^a,b   Machicado, Jorge D ^c   Maco, Vicente ^d   Terashima, Angelica ^d   Marcos, Luis A ^d,e  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL INFILTRATION; DATA EXTRACTION; FASCIOLA HEPATICA; FASCIOLIASIS; FIBROSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; NEOPLASM; NONHUMAN; SCLEROSING CHOLANGITIS; SYSTEMATIC REVIEW; UPREGULATION;

EID: 84992091547     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004962     Document Type: Article

References (48)

1. Fürst T, Duthaler U, Sripa B, Utzinger J, Keiser J, Trematode infections: liver and lung flukes. Infect Dis Clin North Am. 2012;26(2): 399–419. doi: 10.1016/j.idc.2012.03.00822632646
2. Fürst T, Keiser J, Utzinger J, Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12(3): 210–221. doi: 10.1016/S1473-3099(11)70294-822108757
3. International Agency for Research on Cancer (IARC)Biological agents. A review of human carcinogens. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization. Volume 100 B. Int. Agency Res. Cancer 2012: 1–441.
4. Mas-Coma S, Valero MA, Bargues MD, Fascioliasis. Adv Exp Med Biol. 2014;766: 77–114. doi: 10.1007/978-1-4939-0915-5_424903364
5. Marcos LA, Terashima A, Leguia G, Canales M, Espinoza JR, Gotuzzo E, Fasciola hepatica infection in Peru: an emergent disease. Rev Gastroenterol Peru. 2007;27(4): 389–396. 18183272
6. Raymundo LA, Flores VM, Terashima A, Samalvides F, Miranda E, Tantalean et al. Hyperendemicity of human fasciolosis in the Mantaro Valley, Peru: factors for infection with Fasciole hepatica. Rev Gastroenterol Peru. 2004;24(2): 158–164. 15241494
7. Marcos LA, Terashima A, Gotuzzo E, Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis. 2008;21(5): 523–230. doi: 10.1097/QCO.0b013e32830f981818725803
8. Almendras-Jaramillo M, Rivera-Medina J, Seijas-Mogrovejo J, Almendras-Jaramillo K, Hepatic fascioliasis in children: uncommon clinical manifestations. Arq Gastroenterol. 1997;34(4): 241–247. 9629320
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, PRISMA Group: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6: e1000100. doi: 10.1371/journal.pmed.100010019621070
10. Jones EA, Kay JM, Milligan HP, Owens D, Massive infection with Fasciola hepatica in man. The American Journal of Medicine. 1977;63: 836–842. 930954
11. Kabaalioglu A., Ceken K., Alimoglu E., Saba R, Cubuk M, Arsian G, et al. Hepatobiliary fascioliasis: Sonographic and CT findings in 87 patients during the initial phase and long-term follow-up. American Journal of Roentgenology2007;189: 824–828. 17885052
12. Rushton B, Murray M, Hepatic pathology of a primary experimental infection of Fasciola hepatica in sheep. Journal of Comparative Pathology1977;87: 459–470. 908772
13. Marcos LA, Yi P, Machicado A, Andrade R, Samalvides F, Sanchez J, et al. Hepatic fibrosis and Fasciola hepatica infection in cattle. J Helminthol. 2007;81(4): 381–386. 17958928
14. Capucchio MT, Catalano D, Di Marco V, Russo M, Aronica V, Tomaselli A, et al. Natural trematode infestation in feral Nebrodi Black pigs: pathological investigations. Vet Parasitol. 2009;159(1): 37–42. doi: 10.1016/j.vetpar.2008.10.01719038498
15. Wensvoort P, Over HJ, Cellular proliferation of bile ductules and gamma-glutamyl transpeptidase in livers and sera of young cattle following a single infection with Fasciola hepatica. Veterinary Quarterly. 1982;4: 161–172. 6132482
16. Trivilin LO, de Sousa DR, Nunes LC, de Sousa RN, Martins IV, Histopathology aspects and fibrosis evaluation of bovine naturally infected livers by Fasciola hepatica. Archives of Veterinary Science. 2014;19(1): 61–69.
17. Kolodziejczyk L, Laszczyńska M, Masiuk M, Grabowska M, Skrzydlewska E, Immunoexpression of intermediate filaments and morphological changes in the liver and bile duct of rats infected with Fasciola hepatica. Biotech Histochem. 2015;90(7): 477–485. doi: 10.3109/10520295.2015.102171225923046
18. Marcos LA, Terashima A, Yi P, Andrade R, Cubero FJ, Albanis E, et al. Mechanisms of liver fibrosis associated with experimental Fasciola hepatica infection: roles of Fas2 proteinase and hepatic stellate cell activation. J Parasitol. 2011;97(1): 82–87. doi: 10.1645/GE-2420.121348611
19. Rojas CA Alvarez, Ansell BR, Hall RS, Gasser RB, Young ND, et al. Transcriptional analysis identifies key genes involved in metabolism, fibrosis/tissue repair and the immune response against Fasciola hepatica in sheep liver. Parasit Vectors. 2015;8: 124–137. doi: 10.1186/s13071-015-0715-725885344
20. Zafra R, Perez-Ecija RA, Buffoni L, Mendez RE, Martinez-Moreno A, Martinez Moreno FJ, et al. Evaluation of hepatic damage and local immune response in goats immunized with native glutathione S-transferase of Fasciola hepatica. J Comp Pathol. 2010;143(2–3): 110–119. doi: 10.1016/j.jcpa.2010.01.01120185148
21. Tliba O, Chauvin A, Le Vern Y, Boulard C, Sbille P, Evaluation of the hepatic NK cell response during the early phase of Fasciola hepatica infection in rats. Vet Res. 2002;33(3): 327–332. 12056483
22. Perez J, Martin De Las Mulas J, Carrasco L, Gutierrez PN, Martínez-Cruz MS, Martínez-Moreno A, Pathological and immunohistochemical study of the liver and hepatic lymph nodes in goats infected with one or more doses of Fasciola hepatica. Journal of Comparative Pathology. 1999;120(29): 199–210.
23. Mark LG, Isseroff H, Levels of type I and type III collagen in the bile duct of rats infected with Fasciola hepatica. Mol Biochem Parasitol. 1983;8(3): 253–262. 6621619
24. Timoteo O, Maco V, JrMaco V, Neyra V, Yi PJ, Leguia G, et al. Characterization of the humoral immune response in alpacas (Lama pacos) experimentally infected with Fasciola hepatica against cysteine proteinases Fas1 and Fas2 and histopathological findings. Vet Immunol Immunopathol. 2005;106(1–2): 77–86. 15910994
25. Hauser SC, Bynum TE, Abnormalities on ERCP in a case of human fascioliasis. Gastrointestinal Endoscopy1984;30(2): 80–82. 6714606
26. Chung JY, Bae YA, Yun DH, Yan HJ, Kong Y, Experimental murine fascioliasis derives early immune suppression with increased levels of TGF-β and IL-4. Korean J Parasitol. 2012;50(4): 301–308. doi: 10.3347/kjp.2012.50.4.30123230327
27. Gorelik L, Constant S, Flavell RA, Mechanism of transforming growth factor beta-induced inhibition of T helper type 1 differentiation. J Exp Med. 2002;195(11): 1499–1505. 12045248
28. Hanahan D, Weinberg RA, Hallmarks of cancer: the next generation. Cell. 2011;144(5): 646–674. doi: 10.1016/j.cell.2011.02.01321376230
29. Motorna OO, Martin H, Gentile GJ, Gentile JM, Analysis of lacI mutations in Big Blue transgenic mice subjected to parasite-induced inflammation. Mutat Res. 2001;484(1–2): 69–76. 11733073
30. Gentile JM, Gentile GJ, Nannenga B, Johnson M, Blankespoor H, Montero R, Enhanced liver cell mutations in trematode-infected Big Blue transgenic mice. Mutat Res. 1998;400(1–2): 355–360. 9685695
31. Mayer DA, Fried B, The role of helminth infections in carcinogenesis. Adv Parasitol. 2007;65: 239–296. 18063098
32. Montero R, Gentile GJ, Frederick L, McManniss J, Murphy T, Silva G, et al. Induced expression of CYP2A5 in inflamed trematode-infested mouse liver. Mutagenesis. 1999;14(2): 217–220. 10229924
33. Vitovec J, Hepatocellular carcinomas in cattle and their relation to biliary cirrhosis associated with fascioliasis. Veterinary Pathology. 1974;11(6): 548–557.
34. Bitakaramire PK, Bwangamoi O, Experimental infection of calves with Fasciola gigantica. Experimental parasitology. 1969;25: 353–357. 5362596
35. Marinkovic D, Kukolj V, Aleksic-Kovacevic S, Jovanović M, Knežević M, The role of hepatic myofibroblasts in liver cirrhosis in fallow deer (Dama dama) naturally infected with giant liver fluke (Fascioloides magna). BMC Veterinary Research. 2013;9: 45–50. doi: 10.1186/1746-6148-9-4523497565
36. Bertani S, Pineau P, Loli S, Moura J, Zimic M, Deharo E, et al. An atypical age-specific pattern of hepatocellular carcinoma in Peru: a threat for Andean populations. PLoS One. 2013;8(6): e67756. doi: 10.1371/journal.pone.006775623840771
37. Marchio A, Bertani S, Rojas Rojas T, Diomi F, Terris B, Deharo E, et al. A Peculiar Mutation Spectrum Emerging from Young Peruvian Patients with Hepatocellular Carcinoma. PLoS One. 2014;9(12): e114912. doi: 10.1371/journal.pone.011491225502816
38. Tsuda H, Satarug S, Bhudhisawasdi V, Kihana T, Sugimura T, Hirohashi S, Cholangiocarcinomas in Japanese and Thai patients: difference in etiology and incidence of point mutation of the c-Ki-ras proto-oncogene. Mol. Carcinogen. 1992;6: 266–269.
39. Jedlina L, Kozak-Ljunggren M, Wedrychowicz H, In vivo studies of the early, peritoneal, cellular and free radical response in rats infected with Fasciola hepatica by flow cytometric analysis. Exp Parasitol. 2011;128(3):291–297. doi: 10.1016/j.exppara.2011.02.00421354145
40. Kammel HH, Sarhan RM, Saad GA, Biochemical assessment of oxidative status versus liver enzymes in patients with chronic fascioliasis. J Parasit Dis. 2015;39:628–633. doi: 10.1007/s12639-014-0431-926688624
41. Sriraj P, Aukkanimart R, Boonmars T, Juasook A, Sudsarn P, Wonkchalee N, et al. Does a combination of opisthorchiasis and ethyl alcohol consumption enhance early cholangiofibrosis, the risk of cholangiocarcinoma?Parasitol Res. 2013;112(8):2971–2981. doi: 10.1007/s00436-013-3469-123807659
42. Cabada MM, Lopez M, Cruz M, Delgado JR, Hill V, White Ac, JrTreatment failure after multiple courses of triclabendazole among patients with fascioliasis in Cusco, Peru: A case series. PLoS Negl Trop Dis. 2016;10(1):e0004361. doi: 10.1371/journal.pntd.000436126808543
43. Denonpoe Deenonpoe R, Chomvarin C, Pairojkul C, Chamgramol Y, Loukas A, 2015. et al. The carcinogenic liver fluke Opisthorchis viverrini is a reservoir for species of Helicobacter. Asian Pac J Cancer Prev. 2015;16(5):1751–1758. 25773821
44. Boonyanugomol W, Chomvarin C, Sripa B, Bhudhisawasdi V, Khuntikeo N, Hahnvajanawong C, Chamsuwan A, Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford). 2012;14(3): 177–184.
45. Chng KR, Chan SH, Ng AH, Li C, Jusakul A, Bertrand D, et al. Tissue Microbiome Profiling Identifies an Enrichment of Specific Enteric Bacteria in Opisthorchis viverrini Associated Cholangiocarcinoma. EBioMedicine. 2016;8: 195–202. doi: 10.1016/j.ebiom.2016.04.03427428430
46. Smout MJ, Sotillo J, Laha T, Papatpremsiri A, Rinaldi G, Pimenta RN, et al. Carcinogenic Parasite Secretes Growth Factor That Accelerates Wound Healing and Potentially Promotes Neoplasia. PLoS Pathog. 2015;11(10): e1005209. doi: 10.1371/journal.ppat.100520926485648
47. Kim EM, Kim JS, Choi MH, Hong ST, Bae YM, Effects of excretory/secretory products from Clonorchis sinensis and the carcinogen dimethylnitrosamine on the proliferation and cell cycle modulation of human epithelial HEK293T cells. Korean J Parasitol. 2008;46(3): 127–132. doi: 10.3347/kjp.2008.46.3.12718830050
48. Marcos LA, Terashima J, Fascioliasis mimicking malignancy in humans. Peruv. J. Parasitol. 2013;21(1): 55–63.